Zydus Lifesciences In Focus After US FDA Flags Five Issues At Gujarat Plant
Zydus Lifesciences shares will be in focus after the US Food and Drug Administration (FDA) issued five observations following an inspection of the company’s Moraiya facility in Gujarat.
The inspection was conducted between October 5 and October 13, 2026, and highlighted concerns related to data integrity, quality control procedures and manufacturing practices at the facility, sources said.
